Omnia SanaPlant Comparison
Bay-leaf willowherb vs Marjoram
A side-by-side comparison of two medicinal plants — every documented constituent, action, use, safety note and cited source, assembled automatically from the Omnia Sana database.
At a glance
Bay-leaf willowherb and Marjoram: they share 5 indicated uses (arthritis / joint pain, infection (general), inflammation (general), …); 3 pharmacological actions in common.
Evidence face-off — shared uses
| Condition | Bay-leaf willowherb | Marjoram | Verdict |
|---|---|---|---|
| Arthritis / joint pain | 1/10 | 1/10 | Comparable evidence |
| Infection (general) | 1/10 | 2/10 | Comparable evidence |
| Inflammation (general) | 1/10 | 2/10 | Comparable evidence |
| Skin irritation | 1/10 | 1/10 | Comparable evidence |
| Wounds | 1/10 | 1/10 | Comparable evidence |
Evidence scores (1–10) are computed from the tier of each cited source. “Comparable” means the two scores are within one point. Follow a score to its detailed sources.
Key Constituents
Characteristic Epilobium polyphenols underlying the anti-inflammatory and prostate activity; a genus review identifies oenothein B as the dominant constituent and likely driver of the antimicrobial, anti-inflammatory, anti-proliferative and antioxidant effects.
Antioxidant constituents.
Sterols associated with benign prostatic hyperplasia support.
The volatile oil, dominated by terpinen-4-ol and cis-sabinene hydrate in true sweet marjoram, gives most of the antimicrobial and antioxidant activity.
Contribute to antioxidant and anti-inflammatory activity.
Pharmacological Actions
Traditional & Indicated Uses
inferred from anti-inflammatory action
inferred from anticancer action
inferred from antimicrobial action
inferred from anti-inflammatory action
Supports lower urinary tract symptoms of benign prostatic hyperplasia (prostate support) - a genus Epilobium review notes traditional BPH use attributed mainly to oenothein B, though clinical evidence is not yet conclusive
inferred from anti-inflammatory action
Antibacterial, including against Escherichia coli (urinary support); Supports lower urinary tract symptoms of benign prostatic hyperplasia (prostate support) - a genus Epilobium review notes traditional BPH use attributed mainly to oenothein B, though clinical evidence is not yet conclusive
Supports lower urinary tract symptoms of benign prostatic hyperplasia (prostate support) - a genus Epilobium review notes traditional BPH use attributed mainly to oenothein B, though clinical evidence is not yet conclusive
inferred from anti-inflammatory action
inferred from digestive action
inferred from antimicrobial action
inferred from anti-inflammatory action
inferred from sedative action
inferred from antispasmodic action
inferred from antispasmodic action
inferred from anti-inflammatory action
Safety, Cautions & Contraindications
Lower urinary tract / prostate symptoms must be medically assessed first to exclude prostate cancer; willowherb is a supportive measure, not a substitute for diagnosis and treatment.
Well tolerated over three months in clinical use; longer-term safety data are limited.
Generally very safe as a culinary herb. Essential oil should not be ingested in large amounts and avoided in pregnancy. Theoretically may interact with anticoagulants. Avoid medicinal doses during pregnancy.
Duke (2002) rates marjoram (Origanum majorana) as +++ and notes antiviral, antispasmodic, COX-2 inhibitory, and antiseptic activities at the experimental level (score 1). It demonstrates antiherpetic activity in vitro. The plant contains rosmarinic acid and thymol, which contribute to antioxidant and antimicrobial effects. Dose: 1–2 g dried herb as tea three times daily or equivalent preparations. Duke notes the plant is generally well-tolerated with no significant contraindications at usual herbal doses (Duke, 2002).
External Ids
Botanical Description
Slender, softly hairy perennial herb with narrow, lance-shaped leaves and small, four-petalled, pale pink to lilac flowers with a notched tip, borne singly in the upper leaf axils. After flowering, long, narrow seed pods split to release cottony-tufted seeds, typical of the willowherb genus.[13]
Tender perennial subshrub (Lamiaceae), often grown as an annual in cold climates, 20-60 cm tall, with square, downy, much-branched stems. Leaves are opposite, small, grey-green and ovate. Tiny white to pale pink, two-lipped flowers are borne in distinctive knot-like clustered spikes, the origin of the common name 'knotted marjoram'.[6]
Habitat
Grows in damp meadows, ditches, streamsides and waste ground on moist soils; native to Europe and temperate Asia.[13]
Native to Cyprus, Turkey and the eastern Mediterranean, and widely cultivated as a culinary and medicinal herb in gardens worldwide; prefers full sun and well-drained, often calcareous soils.[6]
Harvesting
The flowering aerial parts are cut in summer while in flower, and dried in a warm, shaded, airy place.[13]
The aerial flowering parts are cut just before or at flowering (summer), when essential-oil content is highest, and dried quickly in a warm, shaded, well-ventilated place.[9]
Traditional Uses
Small-flowered willowherb, along with related Epilobium species, has a Central European folk tradition as a supportive remedy for lower urinary tract symptoms associated with benign prostatic hyperplasia (BPH) and prostatitis, and as an antimicrobial and anti-inflammatory herb for minor infections; the traditional prostate-support use is attributed mainly to its oenothein B content, though robust clinical evidence remains limited.[13]
Marjoram has a long Mediterranean culinary-medicinal tradition as a digestive carminative and mild sedative for indigestion, cramping and poor sleep, and as an antiseptic for minor wounds and infections. Modern research confirms antispasmodic, antimicrobial, antioxidant and anti-inflammatory activity from its essential oil and phenolic constituents.[6, 8]
Preparations
Dosage
The EU herbal monograph gives 1.5-2.0 g of the comminuted herb in 250 mL of boiling water as an infusion, twice daily, in adults and elderly; long-term use is possible. Lower urinary tract or prostate symptoms should always be medically assessed first, and the monograph directs that a doctor be consulted if fever, spasms, blood in the urine, painful urination or urinary retention occur. Educational reference only, not a prescription.
References
Lookalikes Review
Drug Class Interactions
Not documented
References & Sources
- Vitalone, A. and Allkanjari, O (2018) 'Epilobium spp: Pharmacology and Phytochemistry', Phytotherapy Research, 32(7), pp. 1229-1240. doi:10.1002/ptr.6072 Traditional / reference
https://doi.org/10.1002/ptr.6072 - Cicero, A.F.G., Allkanjari, O., Busetto, G.M., Cai, T. et al (2019) 'Nutraceutical treatment and prevention of benign prostatic hyperplasia and prostate cancer', Archivio Italiano di Urologia e Andrologia, 91(3), pp. 139-152. doi:10.4081/aiua.2019.3.139 Traditional / reference
https://doi.org/10.4081/aiua.2019.3.139 - Vlase, A.M., Toiu, A., Gligor, O., Muntean, D. et al (2024) 'Investigation of Epilobium hirsutum L. Optimized Extract's Anti-Inflammatory and Antitumor Potential', Plants (Basel), 13(2), pp. 198. doi:10.3390/plants13020198 Preclinical
https://doi.org/10.3390/plants13020198 - Granica, S., Piwowarski, J.P., Czerwinska, M.E. and Kiss, A.K (2014) 'Phytochemistry, pharmacology and traditional uses of different Epilobium species (Onagraceae): a review', Journal of Ethnopharmacology, pp. 316--346. doi:10.1016/j.jep.2014.08.036 Traditional / reference
https://doi.org/10.1016/j.jep.2014.08.036 - Ramstead, A.G., Schepetkin, I.A., Quinn, M.T. and Jutila, M.A (2012) 'Oenothein B, a cyclic dimeric ellagitannin isolated from Epilobium angustifolium, enhances IFN-gamma production by lymphocytes', PLoS One, 7(11), pp. e50546. doi:10.1371/journal.pone.0050546 Preclinical
https://doi.org/10.1371/journal.pone.0050546 - Kiss, A.K., Bazylko, A., Filipek, A., Granica, S., Jaszewska, E., Kiarszys, U., Kosmider, A. and Piwowarski, J (2011) 'Oenothein B's contribution to the anti-inflammatory and antioxidant activity of Epilobium sp', Phytomedicine, 18(7), pp. 557-560. doi:10.1016/j.phymed.2010.10.016 Preclinical
https://doi.org/10.1016/j.phymed.2010.10.016 - Schepetkin, I.A., Kirpotina, L.N., Jakiw, L., Khlebnikov, A.I., Blaskovich, C.L., Jutila, M.A. and Quinn, M.T (2009) 'Immunomodulatory activity of oenothein B isolated from Epilobium angustifolium', Journal of Immunology, 183(10), pp. 6754-6766. doi:10.4049/jimmunol.0901827 Preclinical
https://doi.org/10.4049/jimmunol.0901827 - Ducrey, B., Marston, A., Gohring, S., Hartmann, R.W. and Hostettmann, K (1997) 'Inhibition of 5-alpha-reductase and aromatase by the ellagitannins oenothein A and oenothein B from Epilobium species', Planta Medica, 63(2), pp. 111-114. doi:10.1055/s-2006-957624 Preclinical
https://doi.org/10.1055/s-2006-957624 - Schepetkin, I.A., Ramstead, A.G., Kirpotina, L.N., Voyich, J.M., Jutila, M.A. and Quinn, M.T (2016) 'Therapeutic potential of polyphenols from Epilobium angustifolium (fireweed)', Phytotherapy Research, 30(8), pp. 1287-1297. doi:10.1002/ptr.5648 Meta-analysis / review
https://doi.org/10.1002/ptr.5648 - Merighi, S., Travagli, A., Tedeschi, P., Marchetti, N. and Gessi, S (2021) 'Antioxidant and anti-inflammatory effects of Epilobium parviflorum, Melilotus officinalis and Cardiospermum halicacabum plant extracts in macrophage and microglial cells', Cells, 10(10), pp. 2691. doi:10.3390/cells10102691 Preclinical
https://doi.org/10.3390/cells10102691 - Hevesi Toth, B., Blazics, B. and Kery, A (2009) 'Polyphenol composition and antioxidant capacity of Epilobium species', Journal of Pharmaceutical and Biomedical Analysis, 49(1), pp. 26-31. doi:10.1016/j.jpba.2008.09.047 Preclinical
https://doi.org/10.1016/j.jpba.2008.09.047 - Vitalone, A., McColl, J., Thome, D., Costa, L.G. and Tita, B (2003) 'Characterization of the effect of Epilobium extracts on human cell proliferation', Pharmacology, 69(2), pp. 79-87. doi:10.1159/000072360 Preclinical
https://doi.org/10.1159/000072360 - Steenkamp, V., Gouws, M.C., Gulumian, M., Elgorashi, E.E. and van Staden, J (2005) 'Studies on antibacterial, anti-inflammatory and antioxidant activity of herbal remedies used in the treatment of benign prostatic hyperplasia and prostatitis', Journal of Ethnopharmacology, pp. 2005. doi:10.1016/j.jep.2005.07.007 Traditional / reference
https://doi.org/10.1016/j.jep.2005.07.007 - European Medicines Agency (HMPC) (2015) 'European Union herbal monograph on Epilobium angustifolium L. and/or Epilobium parviflorum Schreb., herba'. Available at: https://www.ema.europa.eu/en/documents/herbal-monograph/final-european-union-herbal-monograph-epilobium-angustifolium-l-andor-epilobium-parviflorum-schreb-herba_en.pdf Traditional / reference
https://www.ema.europa.eu/en/documents/herbal-monograph/final-european-union-herbal-monograph-epilobium-angustifolium-l-andor-epilobium-parviflorum-schreb-herba_en.pdf - Coulson, S., Rao, A., Beck, S.L., Steels, E., Gramotnev, H. and Vitetta, L (2013) 'A phase II randomised double-blind placebo-controlled clinical trial investigating the efficacy and safety of ProstateEZE Max: a herbal medicine preparation (containing Epilobium parviflorum) for the management of symptoms of benign prostatic hypertrophy', Complementary Therapies in Medicine. doi:10.1016/j.ctim.2013.01.007 Randomized trial
https://doi.org/10.1016/j.ctim.2013.01.007
- Rehman, N.U., Ansari, M.N., Ahmad, W. and Ali, A (2024) 'Calcium Channel Inhibitory Effect of Marjoram (Origanum majorana L.): Its Medicinal Use in Diarrhea and Gut Hyperactivity', Frontiers in Bioscience (Landmark Edition), 29(2), pp. 47. doi:10.31083/j.fbl2902047 Preclinical
https://doi.org/10.31083/j.fbl2902047 - Hussein, Z. and Yasir, S.M (2022) 'Origanum majorana attenuates ciprofloxacin-induced nephropathy in rats', Wiadomosci Lekarskie, 75(12), pp. 3046-3049. doi:10.36740/WLek202212126 Preclinical
https://doi.org/10.36740/WLek202212126 - Elfiky, A.M., Ibrahim, R.S., Khattab, A.R., Kadry, M.O. and others (2025) 'Exploring the therapeutic potential of marjoram (Origanum majorana L.) in polycystic ovary syndrome: insights from serum metabolomics, network pharmacology and experimental validation', BMC Complementary Medicine and Therapies, 25(1), pp. 67. doi:10.1186/s12906-025-04774-5 Preclinical
https://doi.org/10.1186/s12906-025-04774-5 - Waller, S.B., Cleff, M.B., de Mattos, C.B., da Silva, C.C. and others (2021) 'Protection of the marjoram (Origanum majorana Linn.) essential oil in cutaneous sporotrichosis caused by Sporothrix brasiliensis', Natural Product Research, 35(17), pp. 2977-2981. doi:10.1080/14786419.2019.1678617 Preclinical
https://doi.org/10.1080/14786419.2019.1678617 - Haj-Husein, I., Tukan, S. and Alkazaleh, F (2016) 'The effect of marjoram (Origanum majorana) tea on the hormonal profile of women with polycystic ovary syndrome: a randomised controlled pilot study', Journal of Human Nutrition and Dietetics, 29(1), pp. 105-111. doi:10.1111/jhn.12290 Randomized trial
https://doi.org/10.1111/jhn.12290 - Bouyahya, A., Chamkhi, I., Benali, T., Guaouguaou, F.E. and others (2021) 'Traditional use, phytochemistry, toxicology, and pharmacology of Origanum majorana L', Journal of Ethnopharmacology, 265, pp. 113318. doi:10.1016/j.jep.2020.113318 Meta-analysis / review
https://doi.org/10.1016/j.jep.2020.113318 - Al-Howiriny, T., Alsheikh, A., Alqasoumi, S., Al-Yahya, M. and others (2009) 'Protective Effect of Origanum majorana L. 'Marjoram' on various models of gastric mucosal injury in rats', The American Journal of Chinese Medicine, 37(3), pp. 531-545. doi:10.1142/S0192415X0900703X Preclinical
https://doi.org/10.1142/S0192415X0900703X - Bina, F. and Rahimi, R (2017) 'Sweet Marjoram: A Review of Ethnopharmacology, Phytochemistry, and Biological Activities', Journal of Evidence-Based Complementary & Alternative Medicine, 22(1), pp. 175-185. doi:10.1177/2156587216650793 Meta-analysis / review
https://doi.org/10.1177/2156587216650793 - Paudel, P.N., Satyal, P., Satyal, R., Setzer, W.N. and others (2022) 'Chemical Composition, Enantiomeric Distribution, Antimicrobial and Antioxidant Activities of Origanum majorana L. Essential Oil from Nepal', Molecules, 27(18), pp. 6136. doi:10.3390/molecules27186136 Preclinical
https://doi.org/10.3390/molecules27186136 - Makrane, H., Aziz, M., Mekhfi, H., Ziyyat, A. and others (2019) 'Origanum majorana L. extract exhibit positive cooperative effects on the main mechanisms involved in acute infectious diarrhea', Journal of Ethnopharmacology, 239, pp. 111503. doi:10.1016/j.jep.2018.09.005 Preclinical
https://doi.org/10.1016/j.jep.2018.09.005 - Baser, K.H.C (2008) 'Biological and pharmacological activities of carvacrol and carvacrol bearing essential oils', 14(29), pp. 3106--3119. doi:10.2174/138161208786404227 Traditional / reference
https://doi.org/10.2174/138161208786404227 - Hoffmann, D (2003) 'Medical Herbalism'. Traditional / reference
https://scholar.google.com/scholar?q=Medical%20Herbalism - Seidler-Lozykowska, K. et al (2016) 'Essential oil content and composition of sweet marjoram (Origanum majorana L.) grown in Poland', 62(1), pp. 37--45. Traditional / reference
https://scholar.google.com/scholar?q=Essential%20oil%20content%20and%20composition%20of%20sweet%20marjoram%20%28Origanum%20majorana%20L.%29%20grown%20in%20Poland - Duke, J.A (2002) 'Handbook of Medicinal Herbs, Second Edition'. Traditional / reference
https://scholar.google.com/scholar?q=Handbook%20of%20Medicinal%20Herbs%2C%20Second%20Edition - Ghasemzadeh Rahbardar, M. and Hosseinzadeh, H (2024) 'Therapeutic potential of hypnotic herbal medicines: A comprehensive review', Phytotherapy Research, 38(6), pp. 3037-3059. doi:10.1002/ptr.8201 Meta-analysis / review
https://doi.org/10.1002/ptr.8201 - Block, K.I., Gyllenhaal, C. and Mead, M.N (2004) 'Safety and efficacy of herbal sedatives in cancer care', Integrative Cancer Therapies, 3(2), pp. 128-148. doi:10.1177/1534735404265003 Meta-analysis / review
https://doi.org/10.1177/1534735404265003
Generated automatically from the Omnia Sana plant database and its cited sources. For educational purposes only — not medical advice. Always consult a qualified practitioner before using medicinal plants.